Literature DB >> 28099403

Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.

Sanjaya K Satapathy1, Jason M Vanatta, Ryan A Helmick, Albert Flowers, Satish K Kedia, Yu Jiang, Bilal Ali, James Eason, Satheesh P Nair, Uzoma N Ibebuogu.   

Abstract

BACKGROUND: Coronary artery disease (CAD) is a significant problem during evaluation for liver transplantation (LT). We aim to assess survival in LT recipients based on presence, severity, extent of CAD, and cardiac events within 90 days of LT.
METHODS: Eighty-seven LT recipients with history of pre-LT angiogram (December 2005 to December 2012) were compared with 2 control groups without prior angiogram, 72 LT recipients matched for cardiovascular risk factors (control group I), and 119 consecutive LT recipients without any CV risk factors (control group II). CAD was assessed by (1) vessel score (≥50% reduction in luminal diameter), and (2) Extent score (Reardon scoring system).
RESULTS: Of the 87 LT recipients (study group), 58 (66.7%) had none or less than 50% stenosis, 29 (33.3%) had obstructive CAD (≥50% stenosis), 7 (8%) with single-vessel disease, and 22 (25.3%) with multivessel disease. In the study group, irrespective of prerevascularization severity of CAD (P = 0.357), number of segments involved (0, 1-2, > 2 segments, P = 0.304) and extent of CAD based on Reardon score (0, 1-9, >10, P = 0.224), comparable posttransplant survival was noted. Overall, patient survival in the revascularized CAD group was comparable to angiogram group without obstructive CAD, and both control group I and control group II (P = 0.184, Log Rank). Postoperative cardiac events within 90 days of LT predicted poor survival in study group as well as control groups.
CONCLUSIONS: Severity or extent of CAD does not impact post-LT survival, if appropriately revascularized. Early postoperative cardiac events are associated with inferior survival in LT recipients, irrespective of underlying CAD.

Entities:  

Mesh:

Year:  2017        PMID: 28099403      PMCID: PMC7228601          DOI: 10.1097/TP.0000000000001647

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  34 in total

1.  Predictive value of stress myocardial perfusion imaging in liver transplant candidates.

Authors:  Charles J Davidson; Mihai Gheorghiade; James D Flaherty; Michael D Elliot; Srinivas P Reddy; Norman C Wang; Sri A Sundaram; Steven L Flamm; Andres T Blei; Michael I Abecassis; Robert O Bonow
Journal:  Am J Cardiol       Date:  2002-02-01       Impact factor: 2.778

2.  A Simulation Based Evaluation of the Asymptotic Power Formulae for Cox Models in Small Sample Cases.

Authors:  Mehmet Kocak; Arzu Onar-Thomas
Journal:  Am Stat       Date:  2012       Impact factor: 8.710

3.  Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation.

Authors:  Haripriya Maddur; Patrick D Bourdillon; Suthat Liangpunsakul; A Joseph Tector; Jonathan A Fridell; Marwan Ghabril; Marco A Lacerda; Charlotte Bourdillon; Changyu Shen; Paul Y Kwo
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

4.  Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study.

Authors:  H G Kemp; R A Kronmal; R E Vlietstra; R L Frye
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

5.  Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.

Authors:  Lisa B Vanwagner; Manali Bhave; Helen S Te; Joe Feinglass; Lisa Alvarez; Mary E Rinella
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

6.  Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates.

Authors:  M E Harinstein; J D Flaherty; A H Ansari; J Robin; C J Davidson; J S Rossi; S L Flamm; A T Blei; R O Bonow; M Abecassis; M Gheorghiade
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

7.  Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease.

Authors:  Jeane M Tsutsui; Sandeep Mukherjee; Abdou Elhendy; Feng Xie; Elizabeth R Lyden; Edward O'Leary; Anna C McGrain; Thomas R Porter
Journal:  Liver Transpl       Date:  2006-04       Impact factor: 5.799

8.  Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates.

Authors:  A Aydinalp; U Bal; I Atar; C Ertan; A Aktaş; A Yildirir; B Ozin; H Mudderisoglu; M Haberal
Journal:  Transplant Proc       Date:  2009-11       Impact factor: 1.066

9.  The predictors of post-transplant coronary events among liver transplant recipients.

Authors:  Mohammad U Malik; Stuart D Russell; Aliaksei Pustavoitau; Matthews Chacko; Arif M Cosar; Carol B Thompson; Panagiotis Trilianos; Nabil N Dagher; Andrew M Cameron; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2016-06-16       Impact factor: 6.047

10.  Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.

Authors:  C L Donovan; P A Marcovitz; J D Punch; D S Bach; K A Brown; M R Lucey; W F Armstrong
Journal:  Transplantation       Date:  1996-04-27       Impact factor: 4.939

View more
  12 in total

1.  Mind the Gap: Statin Underutilization and Impact on Mortality in Liver Transplant Recipients.

Authors:  Patrick T Campbell; Lisa B VanWagner
Journal:  Liver Transpl       Date:  2019-10       Impact factor: 5.799

2.  The relationship between coronary artery disease and cardiovascular events early after liver transplantation.

Authors:  Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui
Journal:  Liver Int       Date:  2019-03-26       Impact factor: 5.828

Review 3.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 4.  Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

Authors:  Naga Swetha Samji; Rajiv Heda; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05

5.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

Review 6.  Cardiac evaluation of the kidney or liver transplant candidate.

Authors:  Paul Emile Levy; Sadiya S Khan; Lisa B VanWagner
Journal:  Curr Opin Organ Transplant       Date:  2021-02-01       Impact factor: 2.640

Review 7.  Cardiac imaging for the assessment of patients being evaluated for liver transplantation.

Authors:  Kameel Kassab; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2021-04-06       Impact factor: 3.872

Review 8.  Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.

Authors:  Eva Montalvá; Manuel Rodríguez-Perálvarez; Annabel Blasi; Santiago Bonanad; Olga Gavín; Loreto Hierro; Laura Lladó; Elba Llop; Juan Carlos Pozo-Laderas; Jordi Colmenero
Journal:  Transplantation       Date:  2022-01-04       Impact factor: 5.385

Review 9.  Medical management of metabolic and cardiovascular complications after liver transplantation.

Authors:  Chiara Becchetti; Melisa Dirchwolf; Vanessa Banz; Jean-François Dufour
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

Review 10.  Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.

Authors:  Pranab M Barman; Lisa B VanWagner
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.